REG - Wellnex Life Limited - Update on Loan Repayment

Wellnex LifeAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nRSC8631Fa&default-theme=true

RNS Number : 8631F  Wellnex Life Limited  03 November 2025

 

 

 

ASX/AIM Announcement
 
   3 November 2025

 

 

Wellnex Life Limited (ASX/AIM: WNX)

 

 

Update on Loan Repayment

 

 

Wellnex Life Limited ("Wellnex" or the "Company") (ASX | AIM: WNX), announces
that, further to the Company's announcement on 21 October 2025 regarding the
repayment of the loan provided by Zack Bozinovski and his wife, the parties
continue to work in good faith to finalise a repayment schedule and are now
targeting to conclude details of the schedule by 7 November 2025.

 

A further update will be issued once the repayment schedule is finalised.

 

This ASX/AIM announcement has been authorised by the Board of Wellnex Life
Limited (ASX/AIM:WNX).

 

For further information, please contact:

 

Wellnex Life Limited (ASX:WNX)
                              Reach Markets

Ash Vesali
                       T: 1300 805 941

Executive Chairman
             E: IR@reachmarkets.com.au

E:  ash.v@wellnexlife.com.au

 

UK Investors

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson
                        Tel: +44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint
Broker)
swykeham@oranacorp.com (mailto:swykeham@oranacorp.com)

Sebastian Wykeham

 

S.P. Angel Corporate Finance LLP (Joint Broker)        Tel: +44 (0)20
3470 0470

David Hignell / Vadim Alexandre

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURFLFSALVLFIIE



            Copyright 2019 Regulatory News Service, all rights reserved